HealthSouth Corporation (HLS) Downgraded by Zacks Investment Research
According to Zacks, “HEALTHSOUTH Corp. is the one of the nation’s largest providers of outpatient surgery and rehabilitative healthcare services. The company provides these services through its national network of inpatient and outpatient healthcare facilities, including inpatient and outpatient rehabilitation facilities, outpatient surgery centers, diagnostic centers, occupational medicine centers, medical centers and other healthcare facilities. “
Several other analysts have also recently weighed in on the stock. Royal Bank Of Canada raised their target price on shares of HealthSouth Corporation from $46.00 to $48.00 and gave the company an outperform rating in a report on Monday, October 31st. Mizuho cut shares of HealthSouth Corporation from a buy rating to a neutral rating in a report on Wednesday, November 9th. RBC Capital Markets reaffirmed an outperform rating and issued a $48.00 target price (up previously from $46.00) on shares of HealthSouth Corporation in a report on Monday, October 31st. Finally, Piper Jaffray Companies assumed coverage on shares of HealthSouth Corporation in a report on Tuesday, January 3rd. They issued a neutral rating and a $45.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the stock. HealthSouth Corporation has a consensus rating of Hold and an average target price of $46.63.
Shares of HealthSouth Corporation (NYSE:HLS) traded up 0.92% during mid-day trading on Tuesday, reaching $41.88. 323,684 shares of the company’s stock traded hands. HealthSouth Corporation has a one year low of $30.26 and a one year high of $43.38. The firm’s 50-day moving average is $41.61 and its 200 day moving average is $40.72. The firm has a market cap of $3.76 billion, a price-to-earnings ratio of 17.46 and a beta of 0.89.
HealthSouth Corporation (NYSE:HLS) last issued its earnings results on Thursday, October 27th. The company reported $0.65 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.05. The firm had revenue of $926.80 million for the quarter, compared to analysts’ expectations of $448.60 million. HealthSouth Corporation had a net margin of 6.31% and a return on equity of 29.27%. The firm’s revenue was up 19.0% compared to the same quarter last year. During the same quarter last year, the company earned $0.52 earnings per share. Analysts predict that HealthSouth Corporation will post $2.57 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: “HealthSouth Corporation (HLS) Downgraded by Zacks Investment Research” was published by Watch List News and is the propert of of Watch List News. If you are viewing this piece on another domain, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece can be accessed at http://www.watchlistnews.com/healthsouth-corporation-hls-downgraded-by-zacks-investment-research/1059986.html.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 17th. Stockholders of record on Tuesday, January 3rd will be given a dividend of $0.24 per share. The ex-dividend date is Thursday, December 29th. This represents a $0.96 dividend on an annualized basis and a dividend yield of 2.31%. HealthSouth Corporation’s dividend payout ratio (DPR) is presently 40.17%.
In other HealthSouth Corporation news, CFO Douglas E. Coltharp bought 6,450 shares of the stock in a transaction dated Wednesday, November 9th. The shares were acquired at an average cost of $39.14 per share, for a total transaction of $252,453.00. Following the completion of the transaction, the chief financial officer now owns 104,637 shares in the company, valued at approximately $4,095,492.18. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, COO Mark J. Tarr bought 6,371 shares of the stock in a transaction dated Wednesday, November 9th. The shares were acquired at an average price of $39.29 per share, for a total transaction of $250,316.59. Following the completion of the transaction, the chief operating officer now owns 238,890 shares of the company’s stock, valued at approximately $9,385,988.10. The disclosure for this purchase can be found here. Insiders own 5.00% of the company’s stock.
Institutional investors have recently made changes to their positions in the company. William Blair Investment Management LLC raised its position in HealthSouth Corporation by 37.7% in the second quarter. William Blair Investment Management LLC now owns 3,061,817 shares of the company’s stock worth $118,860,000 after buying an additional 837,747 shares during the period. Bank of Montreal Can purchased a new position in HealthSouth Corporation during the second quarter worth $22,389,000. Allianz Asset Management AG raised its position in HealthSouth Corporation by 382.0% in the second quarter. Allianz Asset Management AG now owns 716,684 shares of the company’s stock worth $27,822,000 after buying an additional 567,979 shares during the period. Cumberland Partners Ltd raised its position in HealthSouth Corporation by 178.5% in the second quarter. Cumberland Partners Ltd now owns 559,025 shares of the company’s stock worth $21,702,000 after buying an additional 358,325 shares during the period. Finally, Boston Advisors LLC raised its position in HealthSouth Corporation by 224.8% in the third quarter. Boston Advisors LLC now owns 483,333 shares of the company’s stock worth $19,609,000 after buying an additional 334,525 shares during the period. Institutional investors and hedge funds own 97.10% of the company’s stock.
About HealthSouth Corporation
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.